Yesterday, Feb. 24, 2016, 77 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $250.66 to $7,618,160.00.

Highlighted Stocks Traded by Insiders:

Healthcare Services Group (HCSG) - FREE Research Report

McCartney Bryan D, who is Executive Vice President at Healthcare Services Group, sold 1,412 shares at $35.17 on Feb. 24, 2016. Following this transaction, the Executive Vice President owned 106,225 shares meaning that the stake was reduced by 1.31% with the 1,412-share transaction.

The shares most recently traded at $35.08, down $0.09, or 0.26% since the insider transaction. Historical insider transactions for Healthcare Services Group go as follows:

  • 4-Week # shares sold: 2,000
  • 12-Week # shares sold: 2,000
  • 24-Week # shares sold: 2,000

The average volume for Healthcare Services Group has been 350,300 shares per day over the past 30 days. Healthcare Services Group has a market cap of $2.5 billion and is part of the services sector and diversified services industry. Shares are up 0.49% year-to-date as of the close of trading on Wednesday.

Healthcare Services Group, Inc. provides management, administrative, and operating services to the housekeeping, laundry, linen, facility maintenance, and dietary service departments to nursing homes, retirement complexes, rehabilitation centers, and hospitals in the United States. The stock currently has a dividend yield of 2.07%. The company has a P/E ratio of 43.7. Currently, there are 3 analysts who rate Healthcare Services Group a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on HCSG - FREE

TheStreet Quant Ratings

rates Healthcare Services Group as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity and solid stock price performance. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full

Healthcare Services Group Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

MoneyGram International (MGI) - FREE Research Report

Clark Coley, who is Director at MoneyGram International, bought 5,000 shares at $5.42 on Feb. 24, 2016. Following this transaction, the Director owned 39,288 shares meaning that the stake was boosted by 14.58% with the 5,000-share transaction.

The shares most recently traded at $5.20, down $0.22, or 4.23% since the insider transaction. Historical insider transactions for MoneyGram International go as follows:

  • 4-Week # shares bought: 5,000
  • 12-Week # shares bought: 5,000
  • 24-Week # shares bought: 5,000

The average volume for MoneyGram International has been 225,200 shares per day over the past 30 days. MoneyGram International has a market cap of $270.3 million and is part of the financial sector and financial services industry. Shares are down 15.15% year-to-date as of the close of trading on Wednesday.

MoneyGram International, Inc., together with its subsidiaries, provides money transfer and payment services in the United States and internationally. The company operates in two segments, Global Funds Transfer and Financial Paper Products. Currently, there are 3 analysts who rate MoneyGram International a buy, 1 analyst rates it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MGI - FREE

TheStreet Quant Ratings

rates MoneyGram International as a

sell

. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share. Get the full

MoneyGram International Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Maxim Integrated Products (MXIM) - FREE Research Report

Wazzan A R Frank, who is Director at Maxim Integrated Products, sold 11,700 shares at $33.42 on Feb. 24, 2016. Following this transaction, the Director owned 122,433 shares meaning that the stake was reduced by 8.72% with the 11,700-share transaction.

The shares most recently traded at $33.44, up $0.02, or 0.05% since the insider transaction. Historical insider transactions for Maxim Integrated Products go as follows:

  • 4-Week # shares sold: 8,661
  • 12-Week # shares sold: 35,911
  • 24-Week # shares sold: 35,911

The average volume for Maxim Integrated Products has been 3.2 million shares per day over the past 30 days. Maxim Integrated Products has a market cap of $9.4 billion and is part of the technology sector and electronics industry. Shares are down 11.89% year-to-date as of the close of trading on Wednesday.

Maxim Integrated Products, Inc. designs, develops, manufactures, and markets various linear and mixed-signal integrated circuits worldwide. The company also provides a range of high-frequency process technologies and capabilities for use in custom designs. The stock currently has a dividend yield of 3.66%. The company has a P/E ratio of 55.6. Currently, there are 8 analysts who rate Maxim Integrated Products a buy, 1 analyst rates it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MXIM - FREE

TheStreet Quant Ratings

rates Maxim Integrated Products as a

hold

. The company's strengths can be seen in multiple areas, such as its increase in net income, largely solid financial position with reasonable debt levels by most measures and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity, premium valuation and a decline in the stock price during the past year. Get the full

Maxim Integrated Products Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.